Correlation Between Magenta Therapeutics and VectivBio Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Magenta Therapeutics and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magenta Therapeutics and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magenta Therapeutics and VectivBio Holding AG, you can compare the effects of market volatilities on Magenta Therapeutics and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magenta Therapeutics with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magenta Therapeutics and VectivBio Holding.

Diversification Opportunities for Magenta Therapeutics and VectivBio Holding

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Magenta and VectivBio is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Magenta Therapeutics and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Magenta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magenta Therapeutics are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Magenta Therapeutics i.e., Magenta Therapeutics and VectivBio Holding go up and down completely randomly.

Pair Corralation between Magenta Therapeutics and VectivBio Holding

Given the investment horizon of 90 days Magenta Therapeutics is expected to generate 2.95 times more return on investment than VectivBio Holding. However, Magenta Therapeutics is 2.95 times more volatile than VectivBio Holding AG. It trades about 0.16 of its potential returns per unit of risk. VectivBio Holding AG is currently generating about 0.05 per unit of risk. If you would invest  72.00  in Magenta Therapeutics on August 31, 2024 and sell it today you would earn a total of  10.00  from holding Magenta Therapeutics or generate 13.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy71.88%
ValuesDaily Returns

Magenta Therapeutics  vs.  VectivBio Holding AG

 Performance 
       Timeline  
Magenta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Magenta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Magenta Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
VectivBio Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Magenta Therapeutics and VectivBio Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Magenta Therapeutics and VectivBio Holding

The main advantage of trading using opposite Magenta Therapeutics and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magenta Therapeutics position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.
The idea behind Magenta Therapeutics and VectivBio Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing